Holen Sie sich die Stockscreener-App
127.86
2.68%
-3.52
Handel nachbörslich:
127.86
Schlusskurs vom Vortag:
$131.38
Offen:
$125
24-Stunden-Volumen:
1.66M
Relative Volume:
3.33
Marktkapitalisierung:
$7.03B
Einnahmen:
$341.73M
Nettoeinkommen (Verlust:
$-158.61M
KGV:
-47.53
EPS:
-2.69
Netto-Cashflow:
$-81.76M
1W Leistung:
-7.18%
1M Leistung:
-2.38%
6M Leistung:
+20.05%
1J Leistung:
+99.13%
1-Tages-Spanne:
$124.60
$131.09
1-Wochen-Bereich:
$124.60
$139.50
52-Wochen-Spanne:
$59.22
$139.50
Glaukos Corporation Stock (GKOS) Company Profile
Firmenname
Glaukos Corporation
Sektor
Branche
Telefon
949-367-9600
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Eingeleitet | Truist | Buy |
| 2023-11-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-04 | Eingeleitet | Needham | Buy |
| 2022-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-11-03 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Eingeleitet | Jefferies | Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Sell |
| 2020-02-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Hochstufung | Berenberg | Hold → Buy |
| 2019-12-12 | Herabstufung | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Eingeleitet | BTIG Research | Neutral |
| 2018-08-30 | Eingeleitet | Berenberg | Hold |
| 2018-08-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Bestätigt | Stifel | Hold |
| 2018-06-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | Cantor Fitzgerald | Buy |
| 2017-03-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2016-10-27 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Glaukos (NYSE:GKOS) Shares Gap DownHere's What Happened - MarketBeat
Glaukos (NYSE:GKOS) Posts Earnings Results, Beats Expectations By $0.20 EPS - MarketBeat
Earnings call: Glaukos reports strong Q3 growth, raises 2024 guidance - Investing.com
Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Glaukos (NYSE:GKOS) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
GKOS Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - Yahoo Finance
Piper Sandler reaffirms stock target on Glaukos post-Q3 beat - Investing.com
Glaukos price target raised to $145 from $135 at Wells Fargo - TipRanks
BTIG reiterates Buy on Glaukos stock as strong iDose sales support growth outlook - Investing.com
Glaukos Co. (NYSE:GKOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sal - GuruFocus.com
Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sales and Raised Guidance Amid ... - Yahoo Finance
Glaukos Reports Net Sales Increase of 24 Percent in Third Quarter 2024 Behind Strong Glaucoma Sales - Vision Monday
Glaukos reports Q3 adjusted EPS (28c), consensus (48c) - TipRanks
Glaukos Corp. Reports Record Third-Quarter Sales Growth - TipRanks
Glaukos Corp earnings beat by $0.20, revenue topped estimates - Investing.com
Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Glaukos: Q3 Earnings Snapshot - San Antonio Express-News
Glaukos Corp (GKOS) Q3 2024 Earnings: EPS of ($0.39) Beats Estimates, Revenue Surges to $96.7 Million - GuruFocus.com
Glaukos Reports Record Sales Despite Net Loss - TipRanks
Q3 2024 Glaukos Corp Earnings Call Transcript - GuruFocus.com
Glaukos Announces Third Quarter 2024 Financial Results - StockTitan
Glaukos Co. (NYSE:GKOS) Shares Sold by New York State Common Retirement Fund - MarketBeat
Glaukos president sells $316,156 in stock By Investing.com - Investing.com Australia
Glaukos Co. (NYSE:GKOS) COO Sells $316,156.75 in Stock - MarketBeat
Glaukos president sells $316,156 in stock - Investing.com
Earnings To Watch: Glaukos Corp (GKOS) Reports Q3 2024 Result - GuruFocus.com
Possible Bearish Signals With Glaukos Insiders Disposing Stock - Simply Wall St
Creative Planning Purchases 4,937 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
Is Glaukos stock ready for a breakout with iDose demand? Jefferies thinks so By Investing.com - Investing.com South Africa
Glaukos stock soars to all-time high of $136.74 amid robust growth By Investing.com - Investing.com South Africa
Glaukos (NYSE:GKOS) Sets New 1-Year HighHere's Why - MarketBeat
Glaukos stock soars to all-time high of $136.74 amid robust growth - Investing.com
Is Glaukos stock ready for a breakout with iDose demand? Jefferies thinks so - Investing.com Canada
Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Glaukos (GKOS) Scheduled to Post Earnings on Monday - MarketBeat
Glaukos Co. (NYSE:GKOS) Stake Boosted by Assenagon Asset Management S.A. - MarketBeat
Taylor Frigon Capital Management LLC Has $3.64 Million Stake in Glaukos Co. (NYSE:GKOS) - MarketBeat
Allspring Global Investments Holdings LLC Has $50.89 Million Stock Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos shares maintain buy rating as Truist sees iDose boosting company’s growth trajectory into 2025 - Investing.com Australia
Long Term Trading Analysis for (GKOS) - Stock Traders Daily
Glaukos (NYSE:GKOS) Upgraded by StockNews.com to "Hold" - MarketBeat
GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa - MSN
Exchange Traded Concepts LLC Buys New Stake in Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos Corp (GKOS) Stock Price Up 3.09% on Oct 18 - GuruFocus.com
Glaukos eyes FDA approval for ocular therapy after Phase III win - Pharmaceutical Technology
Glaukos shares maintain Overweight rating from Piper Sandler - Investing.com
Glaukos shares maintain Overweight rating from Piper Sandler By Investing.com - Investing.com South Africa
Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety - BioSpace
Glaukos announces positive results in keratoconus treatment trial - Investing.com
Glaukos says Epioxa Phase 3 confirmatory trial meets primary endpoint - TipRanks
Finanzdaten der Glaukos Corporation-Aktie (GKOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):